|
|
Author:
Walter J. Curran, MD; Paul A. Bunn, Jr., MD; James R. Jett, MD; Fred R. Hirsch, MD, PhD; Roy S. Herbst, MD, PhD 
Clinical Care Options
|
|
|
|
|
| Description: |
|
This management series contains modules by experts concerning barriers to patient accrual in non-small-cell lung cancer clinical trials and recommended strategies to improve patient numbers, Adjuvant and Neoadjuvant Therapy for Early-Stage NSCLC, Screening and Imaging in NSCLC, First-Line and Second-Line Treatment of Advanced NSCLC, and Novel Therapeutic Approaches. Membership is required to access material; membership is free.
|
|
| Keywords: |
|
Categories and Staging in NSCLC, Molecular Screening Techniques, PI3K-Akt-mTOR Pathway, Epidemiology of Advanced NSCLC, Non-Small Cell Lung Cancer, diagnosis, clinical trials, therapies, screening, Antiangiogenic Agents, Second-Line Treatment Options for Advanced NSCLC, Targeted Agents for the First-Line Treatment of NSCLC, Adjuvant and Neoadjuvant Chemotherapy, Epidermal Growth Factor Receptor Inhibitors, modules, Multikinase Inhibitors, treatments
|
|
|
Browse in Categories:
|
|
|
|
| More information about this material: |
Primary Audience:
Graduate School,
Professional
Mobile Compatibility:
Not specified at this time
Language:
Chinese,
German,
Italian,
Portuguese,
English,
French,
Spanish
Material Version: 0
Cost Involved:
unsure
Source Code Available:
no
Accessiblity Information Available:
no
Copyright:
unsure
Creative Commons:
no
|
|
 |
About this material: |
Peer Reviews (not reviewed)
Workflow status (accepted for review)
Comments (none)
Learning Exercises (none)
Personal Collections (none)
Accessibility Info (none)
|
|
|
| |
Add your own: |
|
|
| |
|
|
|
|
| |
| |
|
